Pns1000395 47..56
نویسنده
چکیده
Epigenetic changes are inherited alterations in DNA that affect gene expression and function without altering the DNA sequence. DNA methylation is one epigenetic process implicated in human disease that is influenced by diet. DNA methylation involves addition of a 1-C moiety to cytosine groups in DNA. Methylated genes are not transcribed or are transcribed at a reduced rate. Global under-methylation (hypomethylation) and site-specific over-methylation (hypermethylation) are common features of human tumours. DNA hypomethylation, leading to increased expression of specific proto-oncogenes (e.g. genes involved in proliferation or metastasis) can increase the risk of cancer as can hypermethylation and reduced expression of tumour suppressor (TS) genes (e.g. DNA repair genes). DNA methyltransferases (DNMT), together with the methyl donor S-adenosylmethionine (SAM), facilitate DNA methylation. Abnormal DNA methylation is implicated not only in the development of human cancer but also in CVD. Polyphenols, a group of phytochemicals consumed in significant amounts in the human diet, effect risk of cancer. Flavonoids from tea, soft fruits and soya are potent inhibitors of DNMT in vitro, capable of reversing hypermethylation and reactivating TS genes. Folates, a group of water-soluble B vitamins found in high concentration in green leafy vegetables, regulate DNA methylation through their ability to generate SAM. People who habitually consume the lowest level of folate or with the lowest blood folate concentrations have a significantly increased risk of developing several cancers and CVD. This review describes how flavonoids and folates in the human diet alter DNA methylation and may modify the risk of human colon cancer and CVD.
منابع مشابه
Complexity Measure Revisited: a New Algorithm for Classifying Cardiac Arrhythmias
3 21/21=100 44/61=72.1 54/56=96.4 119/138=86.2 4 21/21=100 46/61=75.4 53/56=94.6 120/138=86.9 5 21/21=100 47/61=77 53/56=94.6 121/138=87.7 6 21/21=100 47/61=77 53/56=94.6 121/138=87.7 7 21/21=100 50/61=81.9 52/56=92.8 123/138=89.1 8 21/21=100 50/61=81.9 53/56=94.6 124/138=89.8 9 21/21=100 49/61=80.3 53/56=94.6 123/138=89.1 10 21/21=100 48/61=78.7 51/56=91 120/138=86.9 Performance of SPDR-CM for...
متن کاملInduction of protective immunity against scrub typhus with a 56-kilodalton recombinant antigen fused with a 47-kilodalton antigen of Orientia tsutsugamushi Karp.
A partial gene sequence encoding the 56-kD scrub typhus antigen (Sta56) was amplified from genomic DNA of the Orientia tsutsugamushi Karp strain by a polymerase chain reaction (PCR). The PCR product was ligated with the 47-kD scrub typhus antigen (Sta47) gene in the pQE30/47 expression vector, and the resulting recombinant expression vector was designated pQE30/56-47. A fusion antigen (Sta56-47...
متن کامل5 Nasal Valve Surgery . . . . . . . . . . . . . . . . 75
Abhijit A. Raut and Bhavin Jankharia Introduction . . . . . . . . . . . . . . . . . . . . 35 Imaging Modalities . . . . . . . . . . . . . . . . . 36 Development of Paranasal Sinuses . . . . . . . . . . 36 Anatomy . . . . . . . . . . . . . . . . . . . . . . 37 Mucociliary Apparatus . . . . . . . . . . . . . . . 38 Normal Nasal Variants . . . . . . . . . . . . . . . 38 Sinonasal Disease . . . . ....
متن کاملCumulative Cross Index to Iarc Monographs
A-α-C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40, 245 (1986); Suppl. 7, 56 (1987) Acenaphthene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92, 35 (2010) Acepyrene . . . . . . . . . . . . . . . . . . . . . . . . . . ...
متن کاملCumulative Cross Index to Iarc Monographs
A-α-C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40, 245 (1986); Suppl. 7, 56 (1987) Acenaphthene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92, 35 (2010) Acepyrene . . . . . . . . . . . . . . . . . . . . . . . . . . ...
متن کامل